Los Angeles Capital Management LLC Haemonetics Corp Transaction History

Los Angeles Capital Management LLC

$24.7 Billion
Q3 2024

A detailed history of Los Angeles Capital Management LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 23,954 shares of HAE stock, worth $1.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

23,954

Previous 24,154 0.83%

Holding current value

$1.8 Million

Previous $2 Million 3.65%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$72.45 - $91.58 $14,490 - $18,316	-200 Reduced 0.83%	23,954 $1.93 Million
Q2 2024 Aug 05, 2024	SELL	$81.24 - $97.37 $224,303 - $268,838	-2,761 Reduced 10.26%	24,154 $2 Million
Q1 2024 Apr 05, 2024	BUY	$71.24 - $85.35 $90,973 - $108,991	1,277 Added 4.98%	26,915 $2.3 Million
Q4 2023 Feb 06, 2024	SELL	$80.59 - $92.61 $2.21 Million - $2.54 Million	-27,420 Reduced 51.68%	25,638 $2.19 Million
Q3 2023 Nov 06, 2023	BUY	$82.56 - $93.49 $48,380 - $54,785	586 Added 1.12%	53,058 $4.75 Million
Q2 2023 Aug 03, 2023	BUY	$80.84 - $89.45 $509,130 - $563,356	6,298 Added 13.64%	52,472 $4.47 Million
Q1 2023 May 04, 2023	BUY	$72.75 - $90.6 $2.81 Million - $3.5 Million	38,685 Added 516.56%	46,174 $3.82 Million
Q4 2022 Feb 06, 2023	BUY	$73.85 - $86.14 $553,062 - $645,102	7,489 New	7,489 $589,000
Q2 2021 Aug 05, 2021	BUY	$51.81 - $118.56 $17,304 - $39,599	334 Added 4.76%	7,349 $490,000
Q4 2020 Feb 04, 2021	SELL	$88.75 - $119.95 $309,737 - $418,625	-3,490 Reduced 33.22%	7,015 $833,000
Q3 2020 Nov 02, 2020	SELL	$75.65 - $93.58 $1.56 Million - $1.93 Million	-20,641 Reduced 66.27%	10,505 $917,000
Q2 2020 Aug 05, 2020	SELL	$84.96 - $118.91 $213,504 - $298,820	-2,513 Reduced 7.47%	31,146 $2.79 Million
Q1 2020 May 04, 2020	BUY	$74.34 - $121.82 $1,858 - $3,045	25 Added 0.07%	33,659 $3.35 Million
Q4 2019 Feb 07, 2020	SELL	$114.37 - $129.46 $310,057 - $350,966	-2,711 Reduced 7.46%	33,634 $3.87 Million
Q3 2019 Nov 07, 2019	SELL	$117.16 - $138.52 $959,891 - $1.13 Million	-8,193 Reduced 18.4%	36,345 $4.59 Million
Q2 2019 Jul 29, 2019	SELL	$81.74 - $120.34 $550,927 - $811,091	-6,740 Reduced 13.14%	44,538 $5.36 Million
Q1 2019 Apr 25, 2019	SELL	$83.25 - $102.12 $268,065 - $328,826	-3,220 Reduced 5.91%	51,278 $4.49 Million
Q4 2018 Feb 11, 2019	SELL	$90.66 - $116.63 $66,181 - $85,139	-730 Reduced 1.32%	54,498 $5.45 Million
Q3 2018 Nov 05, 2018	SELL	$89.96 - $114.58 $374,683 - $477,225	-4,165 Reduced 7.01%	55,228 $6.33 Million
Q2 2018 Jul 31, 2018	BUY	$71.53 - $95.75 $503,785 - $674,367	7,043 Added 13.45%	59,393 $5.33 Million
Q1 2018 Apr 27, 2018	BUY	$60.72 - $74.41 $38,253 - $46,878	630 Added 1.22%	52,350 $3.83 Million
Q4 2017 Feb 05, 2018	SELL	$44.96 - $58.99 $1.16 Million - $1.52 Million	-25,849 Reduced 33.32%	51,720 $3 Million
Q3 2017 Nov 06, 2017	BUY	$40.38 - $44.87 $956,198 - $1.06 Million	23,680 Added 43.94%	77,569 $3.48 Million
Q2 2017 Aug 09, 2017	BUY	N/A	53,889	53,889 $2.13 Million

Others Institutions Holding HAE

# of Institutions

330

Shares Held

53.8M

Call Options Held

689K

Put Options Held

345K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.86B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.

Account

Los Angeles Capital Management LLC Haemonetics Corp Transaction History